← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 18, 2013Last known activity
May 31, 2025
Timeline
2010s
- Nov 18, 2013
Cantex Pharmaceuticals— Founded
Drugs by trial phase (19 distinct, 15 trials)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT06831526CollaboratorEarly Phase 1May 31, 2025
- NCT05986851Lead sponsorPhase 2Sep 12, 2023
- NCT05986851Study chairPhase 2Sep 12, 2023
- NCT05789589CollaboratorPhase 1/Phase 2Aug 16, 2023
- NCT05766748Lead sponsorPhase 1/Phase 2Jun 1, 2023
- NCT05635734Lead sponsorPhase 1/Phase 2Dec 31, 2022
- NCT04521335CollaboratorPhase 1Dec 31, 2020
- NCT03714555CollaboratorPhase 2Jun 30, 2019
- NCT02995655CollaboratorPhase 1Apr 7, 2017
- NCT03034135Lead sponsorPhase 2Mar 9, 2017
- NCT02873338Lead sponsorPhase 2Aug 1, 2016
- NCT02873338Study directorPhase 2Aug 1, 2016
- NCT02056782Lead sponsorPhase 1Dec 1, 2013
- NCT02056782Study directorPhase 1Dec 1, 2013
- NCT01843634Lead sponsorEarly Phase 1Aug 1, 2013
Details
- Founded
- Weston, FL, US Nov 18, 2013
- Last known activity
- May 31, 2025